148 related articles for article (PubMed ID: 37142929)
1. Optimization of Cell Viability Assays for Drug Sensitivity Screens.
Larsson P; Parris TZ
Methods Mol Biol; 2023; 2644():287-302. PubMed ID: 37142929
[TBL] [Abstract][Full Text] [Related]
2. Resazurin Live Cell Assay: Setup and Fine-Tuning for Reliable Cytotoxicity Results.
Rodríguez-Corrales JÁ; Josan JS
Methods Mol Biol; 2017; 1647():207-219. PubMed ID: 28809005
[TBL] [Abstract][Full Text] [Related]
3. MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery.
Young J; Margaron Y; Fernandes M; Duchemin-Pelletier E; Michaud J; Flaender M; Lorintiu O; Degot S; Poydenot P
SLAS Discov; 2018 Sep; 23(8):790-806. PubMed ID: 29498891
[TBL] [Abstract][Full Text] [Related]
4. A new approach to drug discovery: high-throughput screening of microbial natural extracts against Aspergillus fumigatus using resazurin.
Monteiro MC; de la Cruz M; Cantizani J; Moreno C; Tormo JR; Mellado E; De Lucas JR; Asensio F; Valiante V; Brakhage AA; Latgé JP; Genilloud O; Vicente F
J Biomol Screen; 2012 Apr; 17(4):542-9. PubMed ID: 22233645
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening normalized to biological response: application to antiviral drug discovery.
Patel DA; Patel AC; Nolan WC; Huang G; Romero AG; Charlton N; Agapov E; Zhang Y; Holtzman MJ
J Biomol Screen; 2014 Jan; 19(1):119-30. PubMed ID: 23860224
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
7. Do We have a Satisfactory Cell Viability Assay? Review of the Currently Commercially-Available Assays.
Halim AB
Curr Drug Discov Technol; 2020; 17(1):2-22. PubMed ID: 30251606
[TBL] [Abstract][Full Text] [Related]
8. Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens.
Larsson P; Engqvist H; Biermann J; Werner Rönnerman E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K; Parris TZ
Sci Rep; 2020 Apr; 10(1):5798. PubMed ID: 32242081
[TBL] [Abstract][Full Text] [Related]
9. Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells.
Efthymiou A; Shaltouki A; Steiner JP; Jha B; Heman-Ackah SM; Swistowski A; Zeng X; Rao MS; Malik N
J Biomol Screen; 2014 Jan; 19(1):32-43. PubMed ID: 24019252
[TBL] [Abstract][Full Text] [Related]
10. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.
Hafner M; Niepel M; Chung M; Sorger PK
Nat Methods; 2016 Jun; 13(6):521-7. PubMed ID: 27135972
[TBL] [Abstract][Full Text] [Related]
11. Drug Screening by Resazurin Colorimetry in Ewing Sarcoma.
Musa J; Cidre-Aranaz F
Methods Mol Biol; 2021; 2226():159-166. PubMed ID: 33326100
[TBL] [Abstract][Full Text] [Related]
12. A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids.
Amin J; Ramachandran K; Williams SJ; Lee A; Novikova L; Stehno-Bittel L
J Pharmacol Toxicol Methods; 2016; 82():83-89. PubMed ID: 27554916
[TBL] [Abstract][Full Text] [Related]
13. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis.
Booij TH; Price LS; Danen EHJ
SLAS Discov; 2019 Jul; 24(6):615-627. PubMed ID: 30817892
[TBL] [Abstract][Full Text] [Related]
14. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
Hampton SL; Kinnaird AI
Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Cell Toxicity Assays.
Murray D; McWilliams L; Wigglesworth M
Methods Mol Biol; 2016; 1439():245-62. PubMed ID: 27317000
[TBL] [Abstract][Full Text] [Related]
16. GPCR assay automation for leveraging lead optimization.
Cvijic ME; Chen J; Kubala S; Nolfo J; Kolodin G; Zhang L
J Lab Autom; 2012 Aug; 17(4):266-74. PubMed ID: 22505604
[TBL] [Abstract][Full Text] [Related]
17. Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform.
Tang H; Duggan S; Richardson PL; Marin V; Warder SE; McLoughlin SM
J Biomol Screen; 2016 Feb; 21(2):201-11. PubMed ID: 26676096
[TBL] [Abstract][Full Text] [Related]
18. Chemical screening in zebrafish for novel biological and therapeutic discovery.
Wiley DS; Redfield SE; Zon LI
Methods Cell Biol; 2017; 138():651-679. PubMed ID: 28129862
[TBL] [Abstract][Full Text] [Related]
19. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.
Kim W; Hendricks GL; Lee K; Mylonakis E
Expert Opin Drug Discov; 2017 Jun; 12(6):625-633. PubMed ID: 28402221
[TBL] [Abstract][Full Text] [Related]
20. Simple fluorescence-based high throughput cell viability assay for filamentous fungi.
Chadha S; Kale SP
Lett Appl Microbiol; 2015 Sep; 61(3):238-44. PubMed ID: 26118969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
